Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash flows from operating activities:
Net (loss) / income from continuing operations	$ (420,000)	$ 2,103,000
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization	195,000	239,000
Equity compensation expense	92,000
Gain on sale of building		(3,357,000)
Provision for losses on accounts receivable		22,000
Impairment of note receivable		95,000
Change in assets and liabilities:
Accounts receivable	707,000	162,000
Inventories	(405,000)	(457,000)
Prepaid expenses and other assets	333,000	219,000
Trade payables	(112,000)	43,000
Accrued liabilities	(87,000)	314,000
Net cash provided by (used in) operating activities	303,000	(617,000)
Cash flows from investing activities:
Purchases of property, plant and equipment	(94,000)	(46,000)
Sale of building		3,500,000
Net cash (used in) provided by investing activities	(94,000)	3,454,000
Cash flows from financing activities:
Repayment of debt and revolving line of credit	(221,000)	(4,792,000)
Proceeds from advance from investor		1,500,000
Proceeds from issuance of long-term debt and revolving line of credit		597,000
Net cash used in financing activities	(221,000)	(2,695,000)
Cash flows from discontinued operations:
Operating activities		473,000
Investing activities
Financing activities		65,000
Net cash provided by (used in) discontinued operations		538,000
Effect of exchange rate changes on cash		(481,000)
Net (decrease) / increase in cash and cash equivalents	(12,000)	199,000
Cash and cash equivalents at beginning of period	66,000	66,000
Cash and cash equivalents at end of period	54,000	265,000
Supplemental disclosure of cash flow information:
Cash payments for interest	169,000	294,000
Accrued Divided and Accretion on preferred stock	404,000	377,000
Issuance of Series C Preferred in exchange from advance from investor		1,500,000
Lease right-of-use assets and lease liability	747,000	3,916,000
Amortization of beneficial conversion feature and deemed dividend on Series C Preferred stock		$ 1,500,000